We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

This study has been terminated.
(Study protocol amended to a new treatment regimen: study DAVFU-006.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00110721
First Posted: May 13, 2005
Last Update Posted: March 6, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Galectin Therapeutics Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2008
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)